615 related articles for article (PubMed ID: 19730431)
1. Tumour suppression by p53: a role for the DNA damage response?
Meek DW
Nat Rev Cancer; 2009 Oct; 9(10):714-23. PubMed ID: 19730431
[TBL] [Abstract][Full Text] [Related]
2. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
[TBL] [Abstract][Full Text] [Related]
3. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
Gjerset RA
J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
[TBL] [Abstract][Full Text] [Related]
4. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
5. Tumour biology: Policing of oncogene activity by p53.
Efeyan A; Garcia-Cao I; Herranz D; Velasco-Miguel S; Serrano M
Nature; 2006 Sep; 443(7108):159. PubMed ID: 16971940
[No Abstract] [Full Text] [Related]
6. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
[TBL] [Abstract][Full Text] [Related]
7. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
8. Unravelling mechanisms of p53-mediated tumour suppression.
Bieging KT; Mello SS; Attardi LD
Nat Rev Cancer; 2014 May; 14(5):359-70. PubMed ID: 24739573
[TBL] [Abstract][Full Text] [Related]
9. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
Rizos H; Scurr LL; Irvine M; Alling NJ; Kefford RF
Cell Cycle; 2007 Jul; 6(14):1741-7. PubMed ID: 17630509
[TBL] [Abstract][Full Text] [Related]
10. Role for PP2A in ARF signaling to p53.
Moule MG; Collins CH; McCormick F; Fried M
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14063-6. PubMed ID: 15383668
[TBL] [Abstract][Full Text] [Related]
11. The ARF tumour suppressor.
Gallagher SJ; Kefford RF; Rizos H
Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Mol Cell Biol; 2003 Apr; 23(7):2463-75. PubMed ID: 12640129
[TBL] [Abstract][Full Text] [Related]
13. p53: guardian of the genome and policeman of the oncogenes.
Efeyan A; Serrano M
Cell Cycle; 2007 May; 6(9):1006-10. PubMed ID: 17457049
[TBL] [Abstract][Full Text] [Related]
14. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
Kamrul HM; Wadhwa R; Kaul SC
Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
[TBL] [Abstract][Full Text] [Related]
15. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
[TBL] [Abstract][Full Text] [Related]
17. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
Khan S; Guevara C; Fujii G; Parry D
Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
[TBL] [Abstract][Full Text] [Related]
18. Cryptic mitochondrial targeting signals in human ARF: clues to controlling cancer?
Henderson BR
Cell Cycle; 2010 Mar; 9(5):866-7. PubMed ID: 20348846
[No Abstract] [Full Text] [Related]
19. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
Agrawal A; Yang J; Murphy RF; Agrawal DK
Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
